专题：Pain Management and Placebo Effect

This cluster of papers explores the neurobiological mechanisms underlying placebo and nocebo effects, focusing on the role of expectation, pain perception, opioid activity, dopamine release, and the use of functional magnetic resonance imaging in clinical trials. It also delves into the impact of hypnosis on pain relief and the modulation of patient outcomes through placebo responses.
最新文献
Meaning Does Not Disappear. Meaning Changes State: A Concept Note on Dynamic Semantic ER and Zen

article Full Text OpenAlex

Does Awareness of Key Reassuring Messages Influence Patient Outcomes in Participants With Chronic Low Back Pain? Secondary Analysis of an Observational Study in Primary Care

article Full Text OpenAlex

Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report

article Full Text OpenAlex

Psilocybin in the Treatment of Cocaine Use Disorder

article Full Text OpenAlex

Evaluating the Readability, Quality, and Reliability of Responses Generated By Artificial Intelligence Programs About Acupuncture for Pain

article Full Text OpenAlex

When medical training amplifies therapeutic nihilism: a cross-national study of healthcare professional attitudes toward stroke recovery in Central Africa

article Full Text OpenAlex

Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins

article Full Text OpenAlex

Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study

article Full Text OpenAlex

<b>Hipnose odontológica no HC da UNICAMP benefício na diminuição da dor e do medo pré e trans cirúrgico</b>

article Full Text OpenAlex

Top-down control of the descending pain modulatory system drives multimodal placebo analgesia

article Full Text OpenAlex

近5年高被引文献
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

article Full Text OpenAlex 1125 FWCI172.0037

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

article Full Text OpenAlex 687 FWCI106.7802

Single-Dose Psilocybin Treatment for Major Depressive Disorder

article Full Text OpenAlex 514 FWCI135.5404

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

article Full Text OpenAlex 426 FWCI70.6277

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

article Full Text OpenAlex 350 FWCI57.7694

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

article Full Text OpenAlex 322 FWCI54.415

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

article Full Text OpenAlex 305 FWCI47.1473

How does generative artificial intelligence impact student creativity?

article Full Text OpenAlex 303 FWCI60.1891

Unraveling Negative Expectations and Nocebo-Related Effects in Musculoskeletal Pain

article Full Text OpenAlex 268 FWCI4.6109

Psychological interventions for chronic, non-specific low back pain: systematic review with network meta-analysis

review Full Text OpenAlex 222 FWCI13.5075